[1] |
Miroshnyk I,Mirza S,Sandler N.Pharmaceutical co-crystals—an opportunity for drug product enhancement[J].Expert Opin Drug Deliv,2009,6(4):333-341.
|
[2] |
Gao Y,Zu H,Zhang JJ.Pharmaceutical cocrystals[J].Prog Chem(化学进展),2010,22(5):829-836.
|
[3] |
Starrett JE,Tortolani DR,Russell J,et al.Synthesis,oral bioavailability determination,and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine(PMEA)[J].J Med Chem,1994,37(12):1857-1864.
|
[4] |
Gao Y,Zu H,Zhang JJ.Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation[J].J Pharm Pharmacol,2011,63(4):483-490.
|
[5] |
Gao Y,Gao J,Liu ZL,et al.Coformer selection based on degradation pathway of drugs:a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals[J].Int J Pharm,2012,438(1):327-335.
|
[6] |
Ma K, Zhang Y, Kan HL, et al. Thermodynamic and kinetic investigation on the crucial factors affecting adefovir dipivoxil-saccharin cocrystallization[J].Pharm Res,2014,31(7):1766-1778.
|
[7] |
Zhang JJ,Zu H,Gao Y.Formation thermodynamics of adefovir dipivoxil-saccharin co-crystals[J].Acta Phys Chim Sin(物理化学学报),2011,27(3):547-552.
|
[8] |
Myerson A.Handbook of Industrial Crystallization[M].Boston:Butterworth-Heinemann,1993:65-87.
|
[9] |
Lee MK,Lee H,Kim I,et al.Novel polymorphic form of adefovir dipivoxil derived from polymer-directed crystallization[J].Pharmazie,2011,66(10):766-770.
|
[10] |
Jung S,Ha JM,Kim IW.Phase Transformation of adefovir dipivoxil/succinic acid cocrystals regulated by polymeric additives[J].Polymers,2013,6(1):1-11.
|
[11] |
Nehm SJ,Rodríguez-Spong B,Rodríguez-Hornedo N.Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation[J].Cryst Growth Des,2006,6(2):592-600.
|
[12] |
Ilevbare GA,Liu H,Edgar KJ,et al.Understanding polymer properties important for crystal growth inhibition-impact of chemically diverse polymers on solution crystal growth of ritonavir[J].Cryst Growth Des,2012,12(6):3133-3143.
|
[13] |
Zheng JM.Medical Polymer Materials(药用高分子材料学)[M].3rd ed.Beijing:Chinese Medical Science Press,2009:200-211
|
[14] |
Schartman RR.On the thermodynamics of cocrystal formation[J].Int J Pharm,2009,365(1):77-80.
|
[15] |
Ozaki S, Kushida I, Yamashita T, et al. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs[J].J Pharm Sci,2013,102(7):2273-2281.
|
[16] |
Xu S,Dai WG.Drug precipitation inhibitors in supersaturable formulations[J].Int J Pharm,2013,453(1):36-43.
|
[17] |
Raghavan SL, Trividic A, Davis AF, et al. Crystallization of hydrocortisone acetate:influence of polymers[J].Int J Pharm,2001,212(2):213-221.
|